The applicant has submitted a dossier in support of the application for authorisation of the food enzyme phospholipase A2 from a genetically modified S. violaceoruber (strain AS‐10). The dossier was updated on 14 April 2016. Additional information was requested from the applicant during the assessment process on 19 May 2020 and was consequently provided (see ‘Documentation provided to EFSA’). Following the reception of additional data by EFSA on 7 December 2020, EFSA requested a clarification teleconference on 17 March 2021, after which the applicant provided additional data on 27 September 2021.
Lambré C., Barat Baviera J.M., Bolognesi C., Cocconcelli P.S., Crebelli R., Gott D.M., Grob K., Lampi E., Mengelers M., Mortensen A., Rivière G., Steffensen I., Tlustos C., Van Loveren H., Vernis L., Zorn H., Maia J., Kovalkovicova N., Lunardi S., di Piazza G., de Sousa R.F., Liu Y, & Chesson A. (2023). Safety evaluation of the food enzyme phospholipase A2 from the genetically modified Streptomyces violaceoruber strain AS‐10. EFSA Journal, 21(2), e07458.
Publication 2023
Assessment process EnzymeFood Phospholipase a2 Strain
Phospholipase A2 from a genetically modified S. violaceoruber (strain AS‐10)
dependent variables
Authorisation of the food enzyme phospholipase A2
control variables
Not explicitly mentioned
controls
No positive or negative controls were explicitly mentioned in the given text.
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required